#

Novo Nordisk

: 114
Novo is expanding its portfolio of drugs to better compete with Eli Lilly / Photo: Novo
News·
Novo licensed a Chinese weight-loss pill for $2.6 billion. What makes it unique?
The maker of Ozempic, Novo, may address the issue of hair loss / Photo: novonordisk.com
News·
The manufacturer of Ozempic is considering entering the hair loss treatment market
Novo disappointed investors who were expecting more concrete plans for turning the business around / Photo: novonordisk.com
News·
Novo's stock plummeted despite sales plans in the billions. What went wrong?
Novo Nordisk to Shorten Its Name to Compete with Eli Lilly / Photo: novonordisk.com
News·
Novo Nordisk will shorten its name and change its logo. Will this help revitalize the business?
Photo: Kittyfly/Shutterstock
News·
Deutsche Bank recommended selling Novo Nordisk shares after they fell 70% from their peak
Eli Lilly Raises Forecast Thanks to the Success of Its Weight-Loss Drugs / Photo: Tada Image / Shutterstock.com
News·
Lilly raised its revenue forecast. This eased fears that the weight-loss boom is on the decline
Novo Nordisk shares fell after the company reported disappointing sales results for its weight-loss drug / Photo: Shutterstock.com / Kittyfly
News·
Weak sales of Wegovy overshadowed Novo's "clearly less-than-impressive" forecast revision
Elon Musks SpaceX will release its first quarterly report this week following its IPO / Photo: X/SpaceX
News·
SpaceX's Earnings Report, the Job Market, and Big Pharma: What Investors Can Expect This Week
The failure of Novo Nordisks drug trials sent its stock tumbling 10% / Photo: JHVEPhoto / Shutterstock
News·
Novo Nordisk shares plummeted 10% after a heart drug trial failed
Novo Nordisk shareholders have succeeded in securing the launch of a judicial investigation into the results of testing for the drug CagriSema / Photo: gguy / Shutterstock
News·
Novo Will Sue Investors Over the Results of a Study on a Weight-Loss Drug
Profits at British pharmaceutical giant AstraZeneca exceeded analysts expectations last quarter. Photo: Konektus Photo/Shutterstock
News·
Oncology drugs helped boost AstraZeneca's profits by 21%. Will the company expand its portfolio?
Novo Nordisk Accuses Eli Lilly of Unfair Advertising / Photo: oleschwander / Shutterstock
News·
Novo has filed a lawsuit against its competitor, Eli Lilly, over advertisements for weight-loss drugs
Load more